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Brief Definit ive Report
Only one candidate HIV vaccine, a canarypox 
vectored gp120 with a protein boost, has shown 
any efficacy (Rerks-Ngarm et al., 2009). The 
limited protection correlated with induction of 
nonneutralizing antibodies to the VI/V2 region 
of the virus Envelope protein (Env; Rerks-
Ngarm et al., 2009; Haynes et al., 2012). This 
modest success has stimulated efforts to design 
vaccines that generate more efficient neutralizing 
antibodies, together with potent CD4+ T cell 
responses capable of providing help to B cells 
and cytotoxic T cells (Burton et al., 2012). Un-
derstanding how the magnitude and specificity 
of these helper T cells can be optimized will be 
critical to the design of an effective vaccine.
Primary immune responses are probably 
influenced strongly by the preexisting reper-
toire of B and T cells. However, characterization 
and quantification of these repertoires is difficult 
due to the extremely low number of circulating 
naive precursor cells (Jenkins et al., 2001; Su 
et al., 2013). Previous studies of naive CD4+  
T cell repertoires in humans and mice have relied 
on magnetic beads to enrich MHC tetramer 
binding cells (Moon et al., 2007; Kwok et al., 
2012; Su et al., 2013). However, although this 
approach gives precise information on responses 
to particular MHC-peptide epitopes, it does 
not measure the total repertoire and misses pre-
viously unknown epitopes. An alternative T cell 
library technique requires no prior knowledge of 
donor HLA type or epitope specificity (Geiger 
et al., 2009). The method presorts circulating 
T cells into naive and memory subsets which 
are seeded at limiting dilution before polyclonal 
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The preexisting HIV-1–specific T cell repertoire must influence both the immunodominance of  
T cells after infection and immunogenicity of vaccines. We directly compared two methods for 
measuring the preexisting CD4+ T cell repertoire in healthy HIV-1–negative volunteers, the HLA-
peptide tetramer enrichment and T cell library technique, and show high concordance (r = 
0.989). Using the library technique, we examined whether naive, central memory, and/or effector 
memory CD4+ T cells specific for overlapping peptides spanning the entire HIV-1 proteome were 
detectable in 10 HLA diverse, HIV-1–unexposed, seronegative donors. HIV-1–specific cells were 
detected in all donors at a mean of 55 cells/million naive cells and 38.9 and 34.1 cells/million in 
central and effector memory subsets. Remarkably, peptide mapping showed most epitopes recog-
nized by naive (88%) and memory (56%) CD4+ T cells had been previously reported in natural 
HIV-1 infection. Furthermore, 83% of epitopes identified in preexisting memory subsets shared 
epitope length matches (8–12 amino acids) with human microbiome proteins, suggestive of a 
possible cross-reactive mechanism. These results underline the power of a proteome-wide analy-
sis of peptide recognition by human T cells for the identification of dominant antigens and 
provide a baseline for optimizing HIV-1–specific helper cell responses by vaccination.
© 2014 Campion et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial–
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performed a direct comparison of the T cell library (Geiger 
et al., 2009) and tetramer enrichment methods (Su et al., 2013) 
using varicella zoster virus (VZV) as a model antigen. We estab-
lished CD4+ T cell libraries of 192 wells per subset from naive 
(CD45RA+CCR7+), central memory (CD45RACCR7+), 
and effector memory (CD45RACCR7) subsets of five 
anonymous HLADRB1*1501+ blood donors. Lines were 
polyclonally expanded for 16–20 d before screening for pro-
liferative response to two VZV epitopes (glycoprotein E [gE] 
and immediate early phosphoprotein 63 [IE63]), which 
are known to be restricted by and commonly detected in 
HLADRB1*1501 donors (Jones et al., 2007; Malavige et al., 
2008). In parallel 25–70 × 106 CD4+ T cells from the same 
time point were screened using custom-made gE and IE63 
HLADRB1*1501 tetramers. We show that the two techniques 
are highly comparable (Pearson’s correlation, r = 0.999), 
with no significant difference in the precursor frequencies 
obtained by each technique (paired Student’s t test, P = 
0.1099; Fig. 1). These data support the T cell library tech-
nique for comprehensive analysis of naive and memory CD4+ 
T cell repertoires.
HIV-1–specific T cells in HIV-1–unexposed, seronegative donors
Naive, central memory, and effector memory CD4+ T cell sub-
sets from 10 HLA diverse (Table S1), healthy, HIV-1 seroneg-
ative donors were screened for HIV-1–specific responses using 
the T cell library method (Geiger et al., 2009). As above, 192 
cell lines per subset were established at limiting dilution and 
polyclonally expanded. Each cell line was screened for reac-
tivity to peptides spanning the entire consensus clade C HIV-1 
proteome, pooled by proteins Gag, Env, Pol, Nef, and a mix of 
Vpr, Vpu, Tat, Rev, and Vif (designated Nef/Acc). Responding 
cells were detected by 3H thymidine incorporation.
HIV-1–specific CD4+ T cells were detected in the naive 
subsets of all donors (Fig. 2 A) at frequencies ranging from 
expansion in the presence of PHA, allogeneic feeder cells, and 
IL-2. Individual cultures are then screened for proliferative 
responses to a protein or series of peptides representing the 
pathogen of interest (Geiger et al., 2009). Combined with ep-
itope mapping and the Poisson distribution, the T cell library 
technique can provide quantitative data on the specificity of 
the entire preexisting naive and memory repertoire.
The existence of HIV-1–specific memory cells in serone-
gative donors was originally suggested by studies of highly 
exposed HIV-1 seronegative (HESN) donors. It has been 
shown that 25–61% of HESNs have demonstrable HIV-1–
specific memory cells, probably primed by exposure to the 
virus. Surprisingly, HIV-1–specific CD4+ T cells were also 
detected in 24–44% of unexposed donors (Ritchie et al., 
2011), although it was not clear whether the latter came from 
cross-reactive memory T cells or naive T cells primed in vitro. 
More recently, the existence of low frequency (1–10/million) 
memory CD4+ T cells, specific for a known HIV-1 Gag epi-
tope, was demonstrated by HLA DR4 tetramers in 50% of 
HIV-1 unexposed HLA DR4+ adults (Su et al., 2013), but it 
was not clear how generalizable the HIV-1 result was beyond 
the single epitope–HLA DR4 combination.
The present study first validates the library technique by 
direct comparison with the tetramer enrichment method for 
measuring precursor T cell frequencies. We then use the T cell 
library technique to provide the first proteome-wide analysis 
of the frequencies and specificities of preexposure HIV-1–
specific naive and memory CD4+ T cells in a HLA diverse 
population of HIV-1 unexposed donors.
RESULTS AND DISCUSSION
Comparison of the T cell library  
technique to tetramer enrichment
Before commencing a proteome-wide screen of the preexisting 
HIV-1–specific naive and memory CD4+ repertories, we first 
Figure 1. Comparison of the CD4+ T cell library and HLA tetramer enrichment methods. The naive and memory CD4+ T cell subsets of 5 
HLADRB15*01 donors were screened in parallel for specificity to two known VZV epitopes (gE and IE63) using the T cell library technique and tetramer 
enrichment protocol. The precursor frequencies obtained from each methodology were subsequently compared using a paired Student’s t test (P = 
0.1099; A), and Pearson’s correlation (r = 0.989; B). Given that the dataset included zero values, a log (x + 1) transformation was applied to all datasets.
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In addition to the naive repertoire, HIV-1–specific T cells 
were also detected within the central memory (Fig. 2 B) and/or 
effector memory (Fig. 2 C) CD4+ T cell compartments of 
all donors. However, the observed frequencies were 15–20-
fold lower (Fig. 3, B–D) than TT-specific memory CD4+  
T cells (Fig. 3 D). The high circulating frequencies of TT- 
specific memory CD4+ T cells are consistent with previous 
reports (Geiger et al., 2009) and reflect successful prior immu-
nization (Sallusto et al., 2010). In contrast, the low frequencies 
28 to 129 cells/million (Fig. 3, A and D), comparable to precur-
sor frequencies of tetanus toxoid (TT)–specific naive CD4+ 
cells (Fig. 3 D). Although the use of a single consensus virus 
sequence allowed a comprehensive assessment of preexisting 
specificity, it must underestimate the total response specific for 
this highly variable virus. However, because 70% of new HIV-1 
infections are established by a single founder virus (Keele et al., 
2008), the frequencies presented herein should realistically pre-
dict an individual’s CD4+ T cell response in acute infection.
Figure 2. HIV-1–specific responses were detected in the circulating naive and memory CD4+ T cell subsets of healthy, HIV-1 seronegative donors. 
For each of 10 donors, a mean of 187 cultured cell lines (each represented by a single dot) per naive (A), central memory (B), and effector memory (C) subsets were 
screened against pools of overlapping peptides spanning the entire HIV-1 proteome. Peptide pools were split according to protein with Nef and Accessory pro-
teins, Vpr, Vpu, Tat, Rev, and Vif included as a single pool referred to as Nef/Acc. All data presented are expressed as the counts per minute, after subtraction of 
background, nonspecific proliferation (delta cpm). Positive responses are defined as SI >5 and >3,000 delta cpm with cutoff criteria represented by a horizontal 
line. Cell lines with background counts of ≥3,000 cpm were excluded from analysis. Proliferative responses to known recall antigen TT are shown for each donor.
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because we included peptides spanning the entire HIV-1 pro-
teome, whereas they focused their analysis to a single known 
epitope; therefore, the findings are fully compatible.
After normalization of the dataset for viral protein size, 
HIV-1 Gag and Env proteins were the immunodominant 
targets of the preexposure naive and memory CD4+ T cell 
subsets (Fig. 3 E), similar to the known patterns of immuno-
dominance in natural HIV-1 infection (Kaufmann et al., 
2004; Ranasinghe et al., 2012). Consistent with the low 
frequency of Pol-specific responses observed after infection 
(Kaufmann et al., 2004; Ranasinghe et al., 2012), relatively 
of HIV-1–specific memory CD4+ T cells in unexposed do-
nors suggest that these T cells arose because of rare cross- 
reactivities with non–HIV-1 antigens.
Considerable inter-donor variation in both the specificity 
and frequency of naive and memory HIV-1–specific CD4+  
T cells was observed (Fig. 3, A–C), probably contributing to 
the great variation in adaptive immune responses seen after 
natural infection and vaccination. Overall, the HIV-1–specific 
memory T cell frequencies detected herein were Y10-fold 
higher than those recently reported using tetramer enrich-
ment (Su et al., 2013). However, this is not a real discrepancy 
Figure 3. Precursor frequencies of HIV-1 and TT–specific T cell responses detected within the naive, and memory CD4+ T cell subsets. These 
were calculated for naive (A), central memory (B) and effector memory (C) subsets using the Poisson distribution. The mean number of antigen-specific 
cells per million was calculated from all 10 donors studied (D) and the dataset normalized according to protein (defined as number of amino acids; E).
Figure 4. Pre-immune and post-infection CD4+ T cell responses frequently respond to the same peptide epitopes. The specificity of 68 cell lines from the 
naive (gray line), central memory (red line), and effector memory (blue line) CD4+ T cell subsets of 5 HIV-1 unexposed seronegative donors was determined using 
epitope mapping (A). Epitopes detected in two or more donors are represented with an *. The LANL database was screened to determine whether mapped epitopes 
had previously detected in natural HIV-1 infection. Epitopes that had previously been detected in HIV-1 infection are represented with a solid line, whereas those 
that had not previously been characterized are shown with a dashed line. The number of mapped epitopes that had previously been reported in natural HIV-1 infec-
tion as compared with the total number of mapped epitopes for each protein is presented in B. To minimize bias, the number of amino acids covered by epitopes 
identified in this study was normalized to the total number of amino acids in HIV-1 reference strain HBX2 covered by previously identified or as yet unknown CD4+ 
T cell epitopes and compared between memory and naive subsets using a Fisher’s exact test (C). Significance (**) was defined as P = 0.0028.
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T cells in a total 68 T cell lines (Fig. 4 and Table S2). Epitopes 
were found to span the entire HIV-1 proteome (Fig. 4) with 
the majority of positive cell lines (76%) showing a single, 
unique peptide specificity, consistent with previous observa-
tions that preexisting memory CD4+ T cell responses are largely 
monoclonal (Geiger et al., 2009; Su et al., 2013).
The functional avidity of a subset of naive (n = 7; Fig. 5 A), 
central memory (n = 11; Fig. 5 B), and effector memory (n = 7; 
Fig. 5 C) CD4+ T cell lines was assessed by peptide titration. 
Overall, the avidities were comparable to those found in 
T cells responding to natural HIV-1 infection, with both high 
and low avidity responses (EC50 3.125–0.001577 µM) detected, 
but no significant difference between subsets.
few naive or memory CD4+ T cells specific for Pol were de-
tected in the preexposure repertoire. Low expression of Pol pro-
tein in infected cells may account for the lack of Pol-specific 
responses after infection but cannot explain why these CD4+ 
T cells are rare in the naive repertoire. Because Pol is a relatively 
conserved protein, it is possible that T cells with this specificity 
are more likely to be deleted during thymic selection due to 
cross-reactivities with endogenous retrovirus sequences.
Peptide specificity and avidity  
of preexisting HIV-1–specific T cells
We next mapped the fine specificity of 68 preexisting naive, 
central memory, and effector memory HIV-1–specific CD4+ 
Figure 5. The avidity of preexisting HIV-1–specific T cell responses detected in the naive and memory CD4+ T cell subsets of 5 healthy HIV-1 
seronegative donors. Responses in naive (A), central memory (B), and effector memory (C) CD4+ T cells were assessed using peptide titration. EC50 values 
were determined for each epitope using interpolated dose–response curves and are presented for each cell line in the adjacent table, with epitopes defined 
according to their position within the HIV-1 reference strain HBX2. All data presented are expressed as the percentage of maximal counts per minute, after 
subtraction of background, nonspecific proliferation (delta cpm). The maximal delta cpm for each cell line is shown in the accompanying table.
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response in natural infection and could be of clinical benefit 
to host (Rosenberg et al., 1997).
Detection of preexisting, cross-reactive memory CD4+  
T cells in unexposed donors is not restricted to HIV-1
Finally, we asked whether detection of cross-reactive memory 
CD4+ T cells in unexposed donors is unique to HIV-1. We 
screened five of the same healthy donors for proliferative re-
sponses to peptides spanning the entire envelope protein of 
the Zaire reference strain of Ebola virus. Because Ebola infection 
is associated with an extremely high mortality rate (WHO, 
1978), our donors cannot have been previously exposed. In 
addition to naive Ebola Env-specific cells (mean 25.26 spe-
cific cells/million; Fig. S1 A), Ebola-specific memory CD4+  
T cells were detected in 4/5 donors tested (mean 142 specific 
cells/million; Fig. S1, B and C). The frequencies of Ebola 
Env-specific T cells were modestly higher than those ob-
served for HIV-1 (Fig. S1 D) but still 10-fold lower in the 
memory subsets than TT-specific memory cells (Fig. S1 D 
and Fig. 3 B). These observations demonstrate that the find-
ings on preexposure CD4+ repertoires reported herein are 
not limited to HIV-1.
Conclusion
The present dataset provides the first comprehensive, system-
atic, and quantitative analysis of the preexposure HIV-1– 
specific CD4+ T cell repertoire in HLA diverse seronegative 
donors. Using peptides spanning the entire HIV-1 proteome, 
we show that both specificity and avidity of the preexposure 
HIV-1–specific CD4+ T cell repertoire has considerable over-
lap with those of CD4+ T cells detected after natural HIV-1 
infection. Furthermore, we suggest that some preexisting mem-
ory HIV-1–specific T cells may have been primed by micro-
bial organisms present within the human microbiome. These 
data help explain immunodominance and immunoprevalence 
in natural HIV-1 infection and the variability in human im-
mune responses to infection and vaccines.
MATERIALS AND METHODS
Study participants and approval. Leukapheresis samples were obtained 
from a total of 15 anonymous HIV-1 seronegative, healthy individuals re-
cruited by the Basel Swiss Red Cross Blood Centre and National Blood Ser-
vice (Bristol, UK). Informed, written consent was obtained from all donors 
and human primary cell protocols were approved by the Federal Office of 
Public Health (N. A000197/2 to F. Sallusto).
HLA typing. DNA was extracted using 5 PRIME Achieve Pure DNA kit 
(Prima Scientific) as per manufacturer’s recommendations. HLA typing 
(Weatherall Institute of Molecular Medicine, Oxford, England, UK) was 
performed using the sequence-specific primer method adapted from Bunce 
(2003), which uses allele-specific primer combination in PCR amplification 
to provide absolute HLA resolution to two digits and high-probability reso-
lution to four digits. HLA types for all donors are shown in Table S1.
Antigen preparation. Synthetic peptides were synthesized by Sigma- 
Aldrich, and/or the Medical Research Council Human Immunology Unit, 
WIMM (Oxford, UK), as 18mers overlapping by 10 aa. The Zaire Ebola Ref-
erence Strain (Zaire-strain Mayinga-76; FASTA ID VGP_EBOZM, UNI-
PROT Q05320; UniProt Consortium, 2012) was used to design peptides 
The immunogens that primed the preexisting HIV-1–
specific memory CD4+ T cells detected within seronegative 
donors are unknown and likely to come from many sources. 
Sequence identity searches (Altschul et al., 1990; Edgar, 2010) 
performed using the reactive HIV-1 peptide sequences iden-
tified potential epitope-length (8–12 aa) subsequence matches 
to a variety of human (Tables S4 B and S5 B) and human mi-
crobiome proteins (Tables S4 and S5). Epitope matches ranged 
from 1 to 230 microbial sequences, with 83% of all HIV-1 
epitopes mapped to the CD4+ memory subsets shown to 
have epitope length (8–12 aa) matches to human microbiome 
proteins (Tables S4 A and S5 A). These data suggest that mi-
crobial proteins could have contributed to T cell priming. 
Our list of potential cross-reactive epitopes (Tables S4 and S5) 
is unlikely to be exhaustive because the degree of sequence 
identity required to activate cross-reactive T cell responses is 
unpredictable, and highly divergent epitopes can elicit cross-
reactive responses in mice (Birnbaum et al., 2014). Moreover, 
database searches are limited to sequenced organisms and 
gene prediction algorithms which may miss cryptic epitopes 
that could be processed and presented during the course of 
infection (Ho and Green, 2006).
Known immunoprevalent epitopes are strongly  
represented in the preexposure repertoire
We next compared the mapped epitopes identified in the 
preexisting repertoire against HIV-1 epitope data stored in 
the Los Alamos National Laboratory (LANL) database (LANL- 
Immunology-Database, http://www.hiv.lanl.gov/content/
immunology). We found that 70% of epitopes detected had 
previously been reported in natural HIV-1 infection (Fig. 4 A 
and Table S3). Many of these epitopes are presented by multi-
ple Class II HLA types, making them immunoprevalent across 
the population (Table S3). Indeed, 10% of the mapped epit-
opes detected within this study were recognized by more 
than one donor (Fig. 4 and Table S2), independent of HLA 
type (Table S1). These data imply that T cell precursor fre-
quency and specificity in both the naive and memory subsets 
before infection could play a large part in determining what 
is immunodominant after infection.
Analysis of the mapped HIV-1 epitopes according to 
CD4+ T cell subset (Fig. 4, B and C) showed that independent 
of donor HLA or antigen sensitivity, 88% of the epitopes 
recognized by preexisting naive CD4+ T cells had previously 
been detected in natural infection, whereas a significantly 
lower proportion (56%) was found for epitopes recognized by 
memory CD4+ T cells (P = 0.0028). HIV-1 preferentially in-
fects HIV-1–specific memory CD4+ T cells (Douek et al., 
2002), and central memory CD4+ T cells in particular are 
rapidly depleted during acute infection leaving very few dur-
ing chronic infection (Younes et al., 2003). Thus, preexisting 
memory HIV-1–specific T cells could be depleted during the 
acute stages of infection, allowing naive T cells to expand 
preferentially. Alternatively, the higher proportion of novel 
epitopes (42%) identified in the preexisting memory CD4+  
T cell repertoire may help to promote diversity of the T cell 
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monocytes (2.5 × 104/well) were pulsed for 2 h with appropriate peptide 
pools, or control antigen before co-culture with T cells. Proliferation was 
measured on day 4 after 16 h incubation with 1 µCi/ml [3H] Thymidine 
(GE Healthcare). A stringent positivity criteria, defined as a stimulation 
index of >5 and a delta value (cpm in response to antigen-pulsed monocytes  
cpm in response to unpulsed monocytes) of >3 × 103 cpm was adopted, 
based upon observations made across multiple negative and positive samples 
assessed by T cell library technique and represented the 99th percentile of 
delta cpm obtained from unstimulated samples (Geiger et al., 2009). Overall, 
<3% of lines were excluded because of nonspecific proliferation. Positive 
cultures identified in the first screening assay were subsequently reanalyzed 
using a three dimensional matrix mapping approach (Roederer and Koup, 
2003) to identify epitope specificity. Precursor frequencies were calculated 
based on the number of negative wells according to the Poisson distribution 
and expressed per million cells (Lefkovits and Waldmann, 1979). EC50 values 
were determined from interpolated dose–response curves using Prism (version 
5.00 for Windows; GraphPad Software).
Epitope analysis. All mapped epitopes were screened against the LANL 
HIV-1 Molecular Immunology database (LANL-Immunology-Database) to 
determine whether they had previously been reported in natural HIV-1. 
HIV-1–specific epitopes mapped in the memory subsets were screened using 
the National Centre for Biotechnology and Information (NCBI) basic local 
alignment sequence tool (BLAST) search tool (Altschul et al., 1990) for 
epitope-length subsequence matches to human proteome and microbiome 
sequences. Short-sequence optimizations were used for BLAST, as the goal 
was detection of sequence similarity rather than of bona fide homology. Ad-
ditional human proteome sequence data were downloaded from UniProt 
(UniProt Consortium, 2012), whereas further human microbiome sequences 
(shotgun sequences derived from body location samples) were obtained from 
the Human Microbiome Project (HMP) clustered gene indices catalog 
(http://www.hmpdacc.org/HMGC/). The UniProt and HMP sequences 
were processed with UBLAST (Edgar, 2010) using highly non-stringent cri-
teria (id, 0.01; evalue, 10,000; maxaccepts, 500,000) to generate matches. 
Both NCBI-BLAST and UBLAST matches were then filtered on the num-
ber of amino acid identities and similarities (Tables S4 and S5). For NCBI, 
BLAST-included epitopes showed a minimum of 8 out of 9 matched amino 
acids with the highest sequence identities showing 12 of 12 matched amino 
acids. Sequences identified with UBLAST search algorithms had a minimum 
of 8 of 8 matched amino acids with the highest levels of sequence identity 
observed with 12 of 12 amino acids matched.
Statistics. Epitope maps obtained from the LANL immunology database 
show 60% of the HIV-1 proteome is covered by previously defined CD4+  
T cell epitopes (LANL-Immunology-Database). Because of this greater pro-
portion of sequence with previously known epitopes, we normalized the 
number of amino acids covered by epitopes identified in this study to the 
number of amino acids from the HBX2 reference strain of HIV-1 which con-
tain known CD4+ T cell epitopes (1,875 aa) or which contained no epitopes 
(1,272 aa). Using a Fisher’s exact test, the percentage of HIV-1 proteome cov-
ered by previously reported epitopes from the naive and memory CD4+ T cell 
subsets could be compared. Significance was defined as P ≤ 0.005.
Pearson’s correlation was used to compare the precursor frequencies 
obtained using the T cell library technique and the tetramer enrichment 
protocol. Because the dataset included zero values, a log (x + 1) transforma-
tion was applied to all data points.
Online supplemental material. Fig. S1 shows data from the naive, central 
and effector memory subsets of five healthy leukapheresis donors who were 
screened for proliferative responses to a pool of peptides spanning the enve-
lope protein of the Zaire reference strain of Ebola virus. Table S1 shows the 
HLA class I and II typing for all 10 donors studied within the context of this 
manuscript. Table S2 shows the amino acid sequence and delta cpm values 
for the 68 HIV-1–specific T cell responses detected in the naive, central 
memory, and effector memory CD4+ T cell subsets of five healthy, HIV-1 
(n = 82) spanning the envelope glycoprotein of Ebola. HIV-1 peptides spanned 
the entire HIV-1 proteome and were designed according to the 2004 consen-
sus clade C HIV-1 sequence (LANL-Sequence-Database, http://www.hiv 
.lanl.gov/). In total, 386 HIV-1–specific peptides were synthesized and pooled 
according to proteins Gag, Env, and Pol, with a single pool comprising Nef 
and Accessory proteins Vif, Tat, Vpr, and Vpu (referred to as NEF/ACC). In 
addition, known VZV epitopes gE (531–545 aa; TSPLLRYAAWTGGLA) 
and IE63 (229–243 aa; QRAIERYAGAETAEY) were synthesized as 15-aa 
peptides and complexed to DRB1*1501 tetramers conjugated to PE (NIH 
Core Tetramer Facility). Quality control checks ensured that the peptide of 
interest was one of the three major peaks by mass spectrometry and all peptide 
stocks were sterility tested before use. All peptides were used at a final con-
centration of 2 µg/ml, and the DMSO concentration in either peptide pools 
or negative control wells did not exceed 0.45% DMSO. Whole protein TT 
(provided by G. Galli, Novartis Vaccines, Siena, Italy) was used as a positive 
control at a final concentration of 5 µg/ml.
Tetramer enrichment protocol. Untouched CD4+ T cells were isolated 
from PBMCs using magnetic microbeads (Miltenyi Biotec). Tetramer staining 
and enrichment was performed as described previously (Su et al., 2013). In 
brief, cells were incubated for 30 min with live/dead Aqua marker (Invitro-
gen), washed, and then labeled with either gE or IE63 tetramers at room tem-
perature for 45 min (14 µg/ml). Surface markers AF700-labeled anti-CD3 
(UCHT3; BD), FITC-labeled anti-CD4 (SK3; BD), Pacific blue–labeled anti-
CD45RA (MHCD45RA28; BD), and PE-cyanine 7 (PECy7)–labeled anti-
CD56 (B159; BD), anti-CD14 (M5E2; BD), and anti-CD8 (SK1; BD) were 
incubated at room temperature for 15 min. Before tetramer enrichment, 
1/10th staining volume was removed and added to TruCount tubes (BD) to 
give an absolute count of the starting number of CD4+ naive and memory 
T cells. The remaining staining volume was enriched for tetramer-positive 
cells using anti-PE microbeads (Miltenyi Biotec) and added to a separate Tru-
Count tube. Samples were acquired using an LSR Fortessa (BD), and the fre-
quency of tetramer-positive cells determined by dividing the absolute counts 
of tetramer positive cells by the starting number of CD4+ naive/memory T cells.
Cell purification and sorting for T cell library. CD14+ monocytes and 
CD4+ T cells were isolated from PBMCs by positive selection with anti-
body-coated microbeads (Miltenyi Biotec). CD14+ monocytes were imme-
diately cryopreserved and stored in liquid nitrogen until required for use as 
antigen-presenting cells in subsequent stimulation assays. CD4+ T cell sub-
sets were cell sorted to 99% purity on a FACSAria (BD) after staining with 
FITC-labeled anti-CD45RA (ALB11; Beckman Coulter), allophycocyanin-
labeled anti-CD4 (SK3; BD), and anti-CCR7 (150503; R&D Systems), fol-
lowed by staining with biotinylated anti-IgG2a (SouthernBiotech) and 
streptavidin–Pacific blue (Invitrogen). PE-cyanine 5 (PC5)–labeled anti-
CD56 (N901 [NHK-1]; Beckman Coulter), anti-CD25 (B1.49.9; Beckman 
Coulter), and anti-CD8 (B9.11; Beckman Coulter) were included as a dump 
channel to exclude natural killer, regulatory, and CD8+ T cells.
T cell libraries. The medium used throughout was RPMI 1640 supple-
mented with 2 mM glutamine, 1% (vol/vol) nonessential amino acids, 1% (vol/
vol) sodium pyruvate, 50 U/ml penicillin, 50 µg/ml streptomycin, and 5% 
human serum (Swiss Red Cross). Cell-sorted naive (CD45RA+CCR7+), cen-
tral memory (CD45RA+CCR7+), and effector memory (CD45RACCR7) 
CD4+ T cell populations were seeded at 2,000 (naive) and 1,000 (memory) 
cells. Cell lines were polyclonally expanded in the presence of 2.5 × 104 irradi-
ated (45Gy) allogeneic feeder cells, 500 IU/ml IL-2, and 1 µg/ml PHA 
(Thermo Fisher Scientific). Throughout the culture period, cells were supple-
mented with exogenous complete media containing 500 IU/ml IL-2 and pro-
gressively transferred from 96- to 24-well tissue culture plates. The full protocol 
has previously been published by Geiger et al. (2009).
Stimulation assays. After a 16–20-d culture period, T cells lines were 
counted and 2.5 × 105 T cells/line removed. T cells were washed 4× in 180 µl 
PBS and rested for a minimum of 4 h at 37°C 5% CO2. Autologous CD14+ 
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seronegative donors. Table S3 shows the results of a Los Alamos database 
search to determine whether any of the mapped epitopes detected in the 
preexposure repertoire had previously been reported in natural infection, 
and lists the citation for instances where the epitope had previously been re-
ported. Table S4 displays the sequence identity matches of HIV-1 epitopes 
detected in the memory CD4+ T cell repertoire to the human microbiome, 
human sequences, and all GenBank/EMBL sequences excepting those clas-
sified as lentiviral, synthetic, or other. Table S5 shows the results of screening 
mapped HIV-1–specific epitopes in the memory CD4+ T cell subsets of HIV-1 
unexposed uninfected donors against predicted genes from the HMP, shotgun 
sequences and human sequences from Uniprot. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20130555/DC1.
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Table S3. HIV-1 specific epitopes mapped in the pre-exposure repertoire were compared against the Los Alamos database to establish whether they had 




HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
'ĂŐϯϯїϱϬ Leuk 7 Central Memory  HLVWASRELERFALNPGL   
   
     --------------L Ramduth et al.͕ϮϬϬϵ 
   
K-I-----------V Chevalier et al.͕ϮϬϭϭ 
   
K-I-----------V Kaufmann et al.͕ϮϬϬϰ 
   
 -I-----------VN Wahren et al., ϭϵϴϵ 
   
 -I-----------VN Koeppe et al., ϮϬϬϲ 
   
 -I-----------VN Jones et al., ϮϬϬϵ 
   
       -------VN Kaufmann et al., ϮϬϬϰ 
   
     -------------- Ranasinghe et al., ϮϬϭ2 
'ĂŐϰϭїϱϴ Leuk 7 Naïve LERFALNPGLLETSEGCK   
   
       ----------- Kaushik et al., ϮϬϬϱ 
   
 ----------------- Ramduth et al.͕ϮϬϬϵ 
'ĂŐϱϳїϳϰ Leuk 7 Central Memory CKQIIKQLQPALQTGTEE   
'ĂŐϳϯїϵϬ >ĞƵŬϵ Central Memory    EELRSLYNTVATLYCVHE   
   
TGS-------------- Chevalier et al.͕ϮϬϭϭ 
   
TGS-------------- Kaufmann et al.͕ϮϬϬϰ 
   
   --------------- Jones et al., ϮϬϬϵ 
 
  
   ----------------- Fonseca et al., ϮϬϬϲ 
'ĂŐϴϭїϵϴ >ĞƵŬϭϬ Naïve         TVATLYCVHEKIEVRDTK   
   
    SLYN---------QR--- Chevalier et al.͕ϮϬϭϭ 
   
    SLYN---------QR--- Kaufmann et al.͕ϮϬϬϰ 
   
    SLYN---------QR--- Geels et al., ϮϬϬϲ 
GĂŐϮϮϴїϮϰϱ >ĞƵŬϵ Central Memory MREPRGSDIAGTTSTLQE   
   
   ---------------QIGWM Boritz et al., ϮϬϬϳ 
   
     -------------QI Koeppe et al., ϮϬϬϲ 
'ĂŐϮϯϲїϮϱϯ >ĞƵŬϵ Central Memory      IAGTTSTLQEQIAWMTSN   
   
PRGSD--------------- Boritz et al., ϮϬϬϳ 
   
  GSD------------ Koeppe et al., ϮϬϬϲ 
   
              ---------PPVPVG Kaushik et al., ϮϬϬϱ 
 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are 
displayed with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
 HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
'ĂŐϮϲϬїϮϳϳ Leuk 7 Effector Memory    DIYKRWIILGLNKIVRMY   
   
PVG--------------- Ramduth et al.͕ϮϬϬϵ 
   
 VGE-----------------SPV De Groot et al., ϮϬϬϱ 
   
     ---------------- Boaz et al., ϮϬϬϯ 
   
     ---------------- Wilson et al., ϮϬϬϭ 
   
     ----------------SPTS Vingert et al., ϮϬϭϬ 
   
     ----------------SPTSILD Rosenberg et al., ϭϵϵϳ 
   
         ------------SP Koeppe et al., ϮϬϬϲ 
   
         ------------SP Jones et al., ϮϬϬϵ 
   
         ------------SPTSI Kaufmann et al., ϮϬϬϰ 
   
          ----------- Kaufmann et al., ϮϬϬϰ 
   
          -----------SPTSILDIR Adams et al., ϭϵϵϳ 
 
  
          -----------SPVSILDIRQGP De Groot et al., ϮϬϬϱ 
'ĂŐϮϲϴїϮϴϱ Leuk 7 Naïve           LGLNKIVRMYSPVSILDI   
   
          ------------T----- Ritchie et al., ϮϬϭϭ 
   
         I------------------RQGP De Groot et al., ϮϬϬϱ 
   
PVGDIYKRWI-------- Ramduth et al.͕ϮϬϬϵ 
   
VGEDIYKRWI------------- De Groot et al., ϮϬϬϱ 
   
     YKRWI---------- Boaz et al., ϮϬϬϯ 
   
     YKRWI----------- Wilson et al., ϮϬϬϭ 
   
     YKRWI------------T- Vingert et al., ϮϬϭϬ 
   
     YKRWI------------T---- Rosenberg et al., ϭϵϵϳ 
   
         I------------ Koeppe et al., ϮϬϬϲ 
   
         -------------- Jones et al., ϮϬϬϵ 
   
         --------------T-- Kaufmann et al., ϮϬϬϰ 
   
          ----------- Kaufmann et al., ϮϬϬϰ 
   
          -------------T----R Adams  et al., ϭϵϵϳ 
'ĂŐϮϳϲїϮϵϯ Leuk 7 Naïve          MYSPVSILDIKQGPKEPF   
   
ILGLNKIVR-------------- De Groot et al., ϮϬϬϱ 
   
 LGLNKIVR----------SPTSILD De Groot et al., ϮϬϬϱ 
   
              -------------RDYV Chevalier et al.͕ϮϬϭϭ 
   
               ------------RDYVDRFY Schrier et al., ϭϵϴϵ 
 
  
                   --------RDYVDR Younes et al., ϮϬϬϯ 
'ĂŐϮϵϮїϯϬϵ Leuk 7 Naïve           PFRDYVDRFFKTLRAEQA   
   
ILDIRQGPKE---------Y  Schrier et al., ϭϵϴϵ 
   
   IRQGPKE-------- Younes et al., ϮϬϬϯ 
   
      GPKE---------Y- Wahren  et al., ϭϵϴϵ 
   
      GPKE---------Y---- Kaufmann et al., ϮϬϬϰ 
   
      QPKE--------------- Adams et al., ϭϵϵϳ 
 
  
         E------------------S Boritz et al., ϮϬϬϳ 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are displayed 
with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
Table S3 (Continued): 
 
Supplementary Table 3 (Continued): 
HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
'ĂŐϯϵϳїϰϭϰ >ĞƵŬϭϬ Naïve KEGHIARNCRAPRKKGCW   
   
   ---K-----------K Kaufmann et al., ϮϬϬϰ 
 
  
   ---KN----------K Chevalier et al.͕ϮϬϭϭ 
'ĂŐϰϮϵїϰϰϲ Leuk 7 Naïve       RQANFLGKIWPSHKGRPG   
   
MKDCTE--------- Wahren et al., ϭϵϴϵ 
   
      ---------------- Kaufmann et al., ϮϬϬϰ 
   
      ---------------- Chevalier et al.͕ϮϬϭϭ 
   
            ------------NFLQSR Kaufmann et al., ϮϬϬϰ 
   
            ------------NFLQSR Ramduth  et al.͕ϮϬϬϵ 
   
            ------------NFLQSR Chevalier et al.͕ϮϬϭϭ 
'ĂŐϰϰϱїϰϲϮ Leuk 7 Naïve PGNFLQNRPEPTAPPAES   
 
Leuk 7 Naïve    ---S-----------FRF Chevalier et al.͕ϮϬϭϭ 
 
>ĞƵŬϭϬ Naïve  -----S---------   
'ĂŐϰϱϯїϰϳϮ Leuk 7 Naïve      PEPTAPPAESFRFEETTP   
   
FLQSR-------E----- Chevalier  et al.͕ϮϬϭϭ 
   
        ----E-----GEE---PSQK Kaufmann et al., ϮϬϬϰ 
'ĂŐϰϲϭїϰϴϬ Leuk 7 Naïve              ESFRFEETTPAPKQEPKD   
   
        TAPPE------------S-- Kaufmann et al., ϮϬϬϰ 
   
                 ----------- Kaushik et al., ϮϬϬϱ 
WŽůϯϭϯїϯϯϬ Leuk 7 Naïve   AIFQSSMTKILEPFRAQN   
   
SP------------- Wilson et al., ϮϬϬϭ 
   
SP------------- Boaz et al., ϮϬϬϯ 
WŽůϯϳϳїϯϵϰ Leuk 7 Central Memory QKEPPFLWMGYELHPDKW   
WŽůϳϭϯїϳϯϬ >ĞƵŬϭϬ Central Memory KVLFLDGIDKAQEEHEKY   
WŽůϳϳϳїϳϵϰ >ĞƵŬϲ Effector Memory QLDCTHLEGKIILVAVHV   
   
        ----------ASGYI Fonseca et al., ϮϬϬϲ 
WŽůϵϰϱїϵϲϮ Leuk 7 Central Memory SRDPIWKGPAKLLWKGEG   
Ŷǀϭїϭϵ >ĞƵŬϵ Central Memory MRVRGILRNCQQWWIWGI   
ŶǀϵїϮϳ >ĞƵŬϵ Central Memory NCQQWWIWGILGFWMLMI   
ŶǀϵϬїϭϬϳ Leuk 7 Naïve          TENFNMWKNDMVDQMHED   
   
PQEVVLVNV------------ Geretti et al., ϭϵϵϰ 
Ŷǀϭϰϴїϭϲϱ LĞƵŬϵ Central Memory          TNTMGEIKNCSFNITTEL   
 
>ĞƵŬϵ Central Memory TNPTSSSWGMMEK------- Mirano-Bascos et al., ϮϬϬϴ 
   
   SSSGRMIMEK---------- Geretti et al., ϭϵϵϰ 
   
          MEK------------SIRNK Mirano-Bascos et al., ϮϬϬϴ 
   
             ------------SIRGKVQK Geretti et al., ϭϵϵϰ 
 
 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are 
displayed with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
Table S3 (Continued): 
 
 HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
Ŷǀϭϱϲїϭϳϯ >ĞƵŬϵ Central Memory       NCSFNITTELRDKKQKVY   
   
   GEIK-------TSIRG-V-- Geretti et al., ϭϵϵϰ 
   
MEKGEIK----Y---SIRNK Mirano-Bascos et al., ϮϬϬϴ 
 
  
      K----------I--- Gaudebout et al., ϭϵϵϳ 
Ŷǀϭϲϰїϭϴϭ >ĞƵŬϴ Effector Memory ELRDKKQKVYALFYRLDI   
   
        ----------VPLTK Harari et al., ϮϬϬϴ 
ŶǀϭϳϮїϭϴϵ >ĞƵŬϴ Effector Memory VYALFYRLDIVPLNENNS   
   
-------------TK Harari et al., ϮϬϬϴ 
ŶǀϮϭϯїϮϯϬ Leuk 7 Naïve       IPIHYCAPAGYAILKCNN   
   
     P----------F-------K Geretti et al., ϭϵϵϰ 
 
  
-----P----------F- Ranasinghe et al., ϮϬϭϮ  
ŶǀϮϲϵїϮϴϲ >ĞƵŬϭϬ Naïve EIIIRSENLTNNAKTIIV   
   
-DIV----F-D-------Q Mirano-Bascos et al., ϮϬϬϴ 
 
  
-VV-----F---------QLNES De Groot et al., ϮϬϬϰ 
ŶǀϮϳϳїϮϵϰ Leuk 7 Naïve       LTNNAKTIIVHLNESVEI   
   
     NF-D------------QIN Malhotra et al., ϮϬϬϯ 
   
 IRSVNF-D-------Q---T- Geretti et al., ϭϵϵϰ 
 
  
   SANF-D-------Q- Wahren et al., ϭϵϴϵ 
Env ϮϴϱїϯϬϮ Leuk 7 Naïve               IVHLNESVEIVCTRPNNN        
   
     NF-D------------QIN Malhotra et al., ϮϬϬϯ 
   
 IRSVNF-D-------Q---T- Geretti et al., ϭϵϵϰ 
Ŷǀϯϯϰїϯϱϭ Leuk 7 Central Memory SEDKWNKTLQKVSKKLKE   
  Leuk ϵ Central Memory     
ŶǀϯϰϮїϯϲϬ Leuk 7 Central Memory LQKVSKKLKEHFPNKTIK   
ŶǀϰϭϭїϰϮϴ Leuk 7 Central Memory NSTITLPCRIKQIINMWQ   
 
>ĞƵŬϭϬ Naïve  D----------------KVG Geretti et al., ϭϵϵϰ͘ 
   
 D----------------KVG Harari et al., ϮϬϬϴ 
   
   ---------------KVGKA Mirano-Bascos et al., ϮϬϬϴ 
   
        ----------KVGKA Koup et al., ϮϬϭϬ 
Env ϰϭϵїϰϯϲ Leuk 7 Naïve         RIKQIINMWQEVGRAMYA   
 
Leuk 7 Central Memory DTITLPC-------------- Geretti et al., ϭϵϵϰ͘ 
 
>ĞƵŬϭϬ Naïve DTITLPC-------------- Harari et al., ϮϬϬϴ 
   
  ITLQC--------------K- Mirano-Bascos et al., ϮϬϬϴ 
 
  
       --------------K- Koup et al., ϮϬϭϬ 
ŶǀϰϯϱїϰϱϮ Leuk 7 Naïve YAPPIAGNITCKSNITGL   
 
 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are displayed 
with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
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HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
Ŷǀϰϳϳїϰϵϰ Leuk 7 Naïve      DNWRSELYKYKVVEIKPL   
   
GGDMR--------------- Geretti et al., ϭϵϵϰ͘ 
   
  DMR------------ Wahren  et al., ϭϵϴϵ 
   
          -------K-----GVAPTKA Geretti et al., 1ϵϵϰ͘ 
 
  
           -------R----GVAPTRAK Mirano-Bascos et al., ϮϬϬϴ 
ŶǀϱϲϱїϱϴϮ Leuk ϵ Effector Memory    MLQLTVWGIKQLQTRVLA   
 
>ĞƵŬϴ Central Memory         -------------VERYLK Malhotra et al., ϮϬϬϯ 
   
QQHL----------- Wahren et al., ϭϵϴϵ 
ŶǀϲϭϯїϲϯϬ >ĞƵŬϴ Effector Memory SWSNKSQEDIWDNMTWMQ   
Ŷǀϲϲϵїϲϴϲ Leuk 7 Naïve   LWNWFDITNWLWYIKIFI   
   
AS-----N------- Wahren et al., ϭϵϴϵ 
ŶǀϳϮϱїϳϰϮ >ĞƵŬϵ Central Memory RGPDRLGRIEEEGGEQDR   
   
      ---------R--DR Schrier et al., ϭϵϴϵ 
ŶǀϳϯϯїϳϱϬ >ĞƵŬϵ Central Memory   IEEEGGEQDRDRSIRLVS   
   
GR---------R--DR Schrier et al., ϭϵϴϵ 
ŶǀϳϳϯїϳϵϬ >ĞƵŬϴ Effector Memory DFILIAARAVELLGRSSL   
ŶǀϳϵϬїϴϬϳ >ĞƵŬϲ Effector Memory           WEALKYLGSLVQYWGLEL   
 
>ĞƵŬϴ Central Memory RIVELLGRRG------------------KNSAVS Berzofsky et al., ϭϵϵϭ 
   
RIVELLGRRG------------------KNSAVS  Berzofsky et al., ϭϵϵϭ 
Ŷǀϳϵϴїϴϭϱ >ĞƵŬϲ Effector Memory SLVQYWGLELKKSAISLL   
ŶǀϴϯϬїϴϰϳ Leuk 7 Central Memory IELIQRICRAIRNIPRRI   
EĞĨϳϯїϵϬ >ĞƵŬϵ Central Memory        QVPLRPMTYKAAFDLSFF   
   
VGFPVRP--------------- De Groot et al., ϮϬϬϱ͘ 
 
  
               ---------H-LKEKGGL Ranasinghe et al., ϮϬϭϮ 
EĞĨϭϮϵїϭϰϲ >ĞƵŬϭϬ Naïve PGPGVRYPLTFGWCFKLV   
   
    ----------Y---PVEPDKVEEANKG Pancré et al., ϮϬϬϳ 
ZĞǀϭϳїϯϰ >ĞƵŬϵ Central Memory RIIKILYQSNPYPKPEGT   
ZĞǀϰϵїϲϲ >ĞƵŬϭϬ Central Memory          QRQIHSISERILSTCLGR   
   
RRRRWRER--------- Blazevic et al., ϭϵϵϱ 
sŝĨϭїϭϴ >ĞƵŬϵ Central Memory MENRWQVLIVWQVDRMKI   
   
   ---------------RTWNSLVK De Groot et al., ϮϬϬϱ͘ 
sŝĨϴϭїϵϴ >ĞƵŬϭϬ Central Memory LGHGVSIEWRLRRYSTQV   
   
----------KQ---- Ranki et al., ϭϵϵϳ 
sƉƵϮїϮϬ >ĞƵŬϴ Central Memory ARVDYRLGVGALIVALII   
sƉƵϭϳїϯϰ >ĞƵŬϵ Central Memory IIAIVVWTIVYIEYRKLL   
sƉƵϯϯїϱϬ >ĞƵŬϭϬ Naïve LLRQRKIDWLIKRIRERA   
sƉƵϰϭїϱϴ >ĞƵŬϵ Central Memory WLIKRIRERAEDSGNESE   
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Table S3. HIV-1 specific epitopes mapped in the pre-exposure repertoire were compared against the Los Alamos database to establish whether they had 




HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
'ĂŐϯϯїϱϬ Leuk 7 Central Memory  HLVWASRELERFALNPGL   
   
     --------------L Ramduth et al.͕ϮϬϬϵ 
   
K-I-----------V Chevalier et al.͕ϮϬϭϭ 
   
K-I-----------V Kaufmann et al.͕ϮϬϬϰ 
   
 -I-----------VN Wahren et al., ϭϵϴϵ 
   
 -I-----------VN Koeppe et al., ϮϬϬϲ 
   
 -I-----------VN Jones et al., ϮϬϬϵ 
   
       -------VN Kaufmann et al., ϮϬϬϰ 
   
     -------------- Ranasinghe et al., ϮϬϭ2 
'ĂŐϰϭїϱϴ Leuk 7 Naïve LERFALNPGLLETSEGCK   
   
       ----------- Kaushik et al., ϮϬϬϱ 
   
 ----------------- Ramduth et al.͕ϮϬϬϵ 
'ĂŐϱϳїϳϰ Leuk 7 Central Memory CKQIIKQLQPALQTGTEE   
'ĂŐϳϯїϵϬ >ĞƵŬϵ Central Memory    EELRSLYNTVATLYCVHE   
   
TGS-------------- Chevalier et al.͕ϮϬϭϭ 
   
TGS-------------- Kaufmann et al.͕ϮϬϬϰ 
   
   --------------- Jones et al., ϮϬϬϵ 
 
  
   ----------------- Fonseca et al., ϮϬϬϲ 
'ĂŐϴϭїϵϴ >ĞƵŬϭϬ Naïve         TVATLYCVHEKIEVRDTK   
   
    SLYN---------QR--- Chevalier et al.͕ϮϬϭϭ 
   
    SLYN---------QR--- Kaufmann et al.͕ϮϬϬϰ 
   
    SLYN---------QR--- Geels et al., ϮϬϬϲ 
GĂŐϮϮϴїϮϰϱ >ĞƵŬϵ Central Memory MREPRGSDIAGTTSTLQE   
   
   ---------------QIGWM Boritz et al., ϮϬϬϳ 
   
     -------------QI Koeppe et al., ϮϬϬϲ 
'ĂŐϮϯϲїϮϱϯ >ĞƵŬϵ Central Memory      IAGTTSTLQEQIAWMTSN   
   
PRGSD--------------- Boritz et al., ϮϬϬϳ 
   
  GSD------------ Koeppe et al., ϮϬϬϲ 
   
              ---------PPVPVG Kaushik et al., ϮϬϬϱ 
 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are 
displayed with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
 HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
'ĂŐϮϲϬїϮϳϳ Leuk 7 Effector Memory    DIYKRWIILGLNKIVRMY   
   
PVG--------------- Ramduth et al.͕ϮϬϬϵ 
   
 VGE-----------------SPV De Groot et al., ϮϬϬϱ 
   
     ---------------- Boaz et al., ϮϬϬϯ 
   
     ---------------- Wilson et al., ϮϬϬϭ 
   
     ----------------SPTS Vingert et al., ϮϬϭϬ 
   
     ----------------SPTSILD Rosenberg et al., ϭϵϵϳ 
   
         ------------SP Koeppe et al., ϮϬϬϲ 
   
         ------------SP Jones et al., ϮϬϬϵ 
   
         ------------SPTSI Kaufmann et al., ϮϬϬϰ 
   
          ----------- Kaufmann et al., ϮϬϬϰ 
   
          -----------SPTSILDIR Adams et al., ϭϵϵϳ 
 
  
          -----------SPVSILDIRQGP De Groot et al., ϮϬϬϱ 
'ĂŐϮϲϴїϮϴϱ Leuk 7 Naïve           LGLNKIVRMYSPVSILDI   
   
          ------------T----- Ritchie et al., ϮϬϭϭ 
   
         I------------------RQGP De Groot et al., ϮϬϬϱ 
   
PVGDIYKRWI-------- Ramduth et al.͕ϮϬϬϵ 
   
VGEDIYKRWI------------- De Groot et al., ϮϬϬϱ 
   
     YKRWI---------- Boaz et al., ϮϬϬϯ 
   
     YKRWI----------- Wilson et al., ϮϬϬϭ 
   
     YKRWI------------T- Vingert et al., ϮϬϭϬ 
   
     YKRWI------------T---- Rosenberg et al., ϭϵϵϳ 
   
         I------------ Koeppe et al., ϮϬϬϲ 
   
         -------------- Jones et al., ϮϬϬϵ 
   
         --------------T-- Kaufmann et al., ϮϬϬϰ 
   
          ----------- Kaufmann et al., ϮϬϬϰ 
   
          -------------T----R Adams  et al., ϭϵϵϳ 
'ĂŐϮϳϲїϮϵϯ Leuk 7 Naïve          MYSPVSILDIKQGPKEPF   
   
ILGLNKIVR-------------- De Groot et al., ϮϬϬϱ 
   
 LGLNKIVR----------SPTSILD De Groot et al., ϮϬϬϱ 
   
              -------------RDYV Chevalier et al.͕ϮϬϭϭ 
   
               ------------RDYVDRFY Schrier et al., ϭϵϴϵ 
 
  
                   --------RDYVDR Younes et al., ϮϬϬϯ 
'ĂŐϮϵϮїϯϬϵ Leuk 7 Naïve           PFRDYVDRFFKTLRAEQA   
   
ILDIRQGPKE---------Y  Schrier et al., ϭϵϴϵ 
   
   IRQGPKE-------- Younes et al., ϮϬϬϯ 
   
      GPKE---------Y- Wahren  et al., ϭϵϴϵ 
   
      GPKE---------Y---- Kaufmann et al., ϮϬϬϰ 
   
      QPKE--------------- Adams et al., ϭϵϵϳ 
 
  
         E------------------S Boritz et al., ϮϬϬϳ 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are displayed 
with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
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HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
'ĂŐϯϵϳїϰϭϰ >ĞƵŬϭϬ Naïve KEGHIARNCRAPRKKGCW   
   
   ---K-----------K Kaufmann et al., ϮϬϬϰ 
 
  
   ---KN----------K Chevalier et al.͕ϮϬϭϭ 
'ĂŐϰϮϵїϰϰϲ Leuk 7 Naïve       RQANFLGKIWPSHKGRPG   
   
MKDCTE--------- Wahren et al., ϭϵϴϵ 
   
      ---------------- Kaufmann et al., ϮϬϬϰ 
   
      ---------------- Chevalier et al.͕ϮϬϭϭ 
   
            ------------NFLQSR Kaufmann et al., ϮϬϬϰ 
   
            ------------NFLQSR Ramduth  et al.͕ϮϬϬϵ 
   
            ------------NFLQSR Chevalier et al.͕ϮϬϭϭ 
'ĂŐϰϰϱїϰϲϮ Leuk 7 Naïve PGNFLQNRPEPTAPPAES   
 
Leuk 7 Naïve    ---S-----------FRF Chevalier et al.͕ϮϬϭϭ 
 
>ĞƵŬϭϬ Naïve  -----S---------   
'ĂŐϰϱϯїϰϳϮ Leuk 7 Naïve      PEPTAPPAESFRFEETTP   
   
FLQSR-------E----- Chevalier  et al.͕ϮϬϭϭ 
   
        ----E-----GEE---PSQK Kaufmann et al., ϮϬϬϰ 
'ĂŐϰϲϭїϰϴϬ Leuk 7 Naïve              ESFRFEETTPAPKQEPKD   
   
        TAPPE------------S-- Kaufmann et al., ϮϬϬϰ 
   
                 ----------- Kaushik et al., ϮϬϬϱ 
WŽůϯϭϯїϯϯϬ Leuk 7 Naïve   AIFQSSMTKILEPFRAQN   
   
SP------------- Wilson et al., ϮϬϬϭ 
   
SP------------- Boaz et al., ϮϬϬϯ 
WŽůϯϳϳїϯϵϰ Leuk 7 Central Memory QKEPPFLWMGYELHPDKW   
WŽůϳϭϯїϳϯϬ >ĞƵŬϭϬ Central Memory KVLFLDGIDKAQEEHEKY   
WŽůϳϳϳїϳϵϰ >ĞƵŬϲ Effector Memory QLDCTHLEGKIILVAVHV   
   
        ----------ASGYI Fonseca et al., ϮϬϬϲ 
WŽůϵϰϱїϵϲϮ Leuk 7 Central Memory SRDPIWKGPAKLLWKGEG   
Ŷǀϭїϭϵ >ĞƵŬϵ Central Memory MRVRGILRNCQQWWIWGI   
ŶǀϵїϮϳ >ĞƵŬϵ Central Memory NCQQWWIWGILGFWMLMI   
ŶǀϵϬїϭϬϳ Leuk 7 Naïve          TENFNMWKNDMVDQMHED   
   
PQEVVLVNV------------ Geretti et al., ϭϵϵϰ 
Ŷǀϭϰϴїϭϲϱ LĞƵŬϵ Central Memory          TNTMGEIKNCSFNITTEL   
 
>ĞƵŬϵ Central Memory TNPTSSSWGMMEK------- Mirano-Bascos et al., ϮϬϬϴ 
   
   SSSGRMIMEK---------- Geretti et al., ϭϵϵϰ 
   
          MEK------------SIRNK Mirano-Bascos et al., ϮϬϬϴ 
   
             ------------SIRGKVQK Geretti et al., ϭϵϵϰ 
 
 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are 
displayed with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
Table S3 (Continued): 
 
 HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
Ŷǀϭϱϲїϭϳϯ >ĞƵŬϵ Central Memory       NCSFNITTELRDKKQKVY   
   
   GEIK-------TSIRG-V-- Geretti et al., ϭϵϵϰ 
   
MEKGEIK----Y---SIRNK Mirano-Bascos et al., ϮϬϬϴ 
 
  
      K----------I--- Gaudebout et al., ϭϵϵϳ 
Ŷǀϭϲϰїϭϴϭ >ĞƵŬϴ Effector Memory ELRDKKQKVYALFYRLDI   
   
        ----------VPLTK Harari et al., ϮϬϬϴ 
ŶǀϭϳϮїϭϴϵ >ĞƵŬϴ Effector Memory VYALFYRLDIVPLNENNS   
   
-------------TK Harari et al., ϮϬϬϴ 
ŶǀϮϭϯїϮϯϬ Leuk 7 Naïve       IPIHYCAPAGYAILKCNN   
   
     P----------F-------K Geretti et al., ϭϵϵϰ 
 
  
-----P----------F- Ranasinghe et al., ϮϬϭϮ  
ŶǀϮϲϵїϮϴϲ >ĞƵŬϭϬ Naïve EIIIRSENLTNNAKTIIV   
   
-DIV----F-D-------Q Mirano-Bascos et al., ϮϬϬϴ 
 
  
-VV-----F---------QLNES De Groot et al., ϮϬϬϰ 
ŶǀϮϳϳїϮϵϰ Leuk 7 Naïve       LTNNAKTIIVHLNESVEI   
   
     NF-D------------QIN Malhotra et al., ϮϬϬϯ 
   
 IRSVNF-D-------Q---T- Geretti et al., ϭϵϵϰ 
 
  
   SANF-D-------Q- Wahren et al., ϭϵϴϵ 
Env ϮϴϱїϯϬϮ Leuk 7 Naïve               IVHLNESVEIVCTRPNNN        
   
     NF-D------------QIN Malhotra et al., ϮϬϬϯ 
   
 IRSVNF-D-------Q---T- Geretti et al., ϭϵϵϰ 
Ŷǀϯϯϰїϯϱϭ Leuk 7 Central Memory SEDKWNKTLQKVSKKLKE   
  Leuk ϵ Central Memory     
ŶǀϯϰϮїϯϲϬ Leuk 7 Central Memory LQKVSKKLKEHFPNKTIK   
ŶǀϰϭϭїϰϮϴ Leuk 7 Central Memory NSTITLPCRIKQIINMWQ   
 
>ĞƵŬϭϬ Naïve  D----------------KVG Geretti et al., ϭϵϵϰ͘ 
   
 D----------------KVG Harari et al., ϮϬϬϴ 
   
   ---------------KVGKA Mirano-Bascos et al., ϮϬϬϴ 
   
        ----------KVGKA Koup et al., ϮϬϭϬ 
Env ϰϭϵїϰϯϲ Leuk 7 Naïve         RIKQIINMWQEVGRAMYA   
 
Leuk 7 Central Memory DTITLPC-------------- Geretti et al., ϭϵϵϰ͘ 
 
>ĞƵŬϭϬ Naïve DTITLPC-------------- Harari et al., ϮϬϬϴ 
   
  ITLQC--------------K- Mirano-Bascos et al., ϮϬϬϴ 
 
  
       --------------K- Koup et al., ϮϬϭϬ 
ŶǀϰϯϱїϰϱϮ Leuk 7 Naïve YAPPIAGNITCKSNITGL   
 
 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are displayed 
with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
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HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
Ŷǀϰϳϳїϰϵϰ Leuk 7 Naïve      DNWRSELYKYKVVEIKPL   
   
GGDMR--------------- Geretti et al., ϭϵϵϰ͘ 
   
  DMR------------ Wahren  et al., ϭϵϴϵ 
   
          -------K-----GVAPTKA Geretti et al., 1ϵϵϰ͘ 
 
  
           -------R----GVAPTRAK Mirano-Bascos et al., ϮϬϬϴ 
ŶǀϱϲϱїϱϴϮ Leuk ϵ Effector Memory    MLQLTVWGIKQLQTRVLA   
 
>ĞƵŬϴ Central Memory         -------------VERYLK Malhotra et al., ϮϬϬϯ 
   
QQHL----------- Wahren et al., ϭϵϴϵ 
ŶǀϲϭϯїϲϯϬ >ĞƵŬϴ Effector Memory SWSNKSQEDIWDNMTWMQ   
Ŷǀϲϲϵїϲϴϲ Leuk 7 Naïve   LWNWFDITNWLWYIKIFI   
   
AS-----N------- Wahren et al., ϭϵϴϵ 
ŶǀϳϮϱїϳϰϮ >ĞƵŬϵ Central Memory RGPDRLGRIEEEGGEQDR   
   
      ---------R--DR Schrier et al., ϭϵϴϵ 
ŶǀϳϯϯїϳϱϬ >ĞƵŬϵ Central Memory   IEEEGGEQDRDRSIRLVS   
   
GR---------R--DR Schrier et al., ϭϵϴϵ 
ŶǀϳϳϯїϳϵϬ >ĞƵŬϴ Effector Memory DFILIAARAVELLGRSSL   
ŶǀϳϵϬїϴϬϳ >ĞƵŬϲ Effector Memory           WEALKYLGSLVQYWGLEL   
 
>ĞƵŬϴ Central Memory RIVELLGRRG------------------KNSAVS Berzofsky et al., ϭϵϵϭ 
   
RIVELLGRRG------------------KNSAVS  Berzofsky et al., ϭϵϵϭ 
Ŷǀϳϵϴїϴϭϱ >ĞƵŬϲ Effector Memory SLVQYWGLELKKSAISLL   
ŶǀϴϯϬїϴϰϳ Leuk 7 Central Memory IELIQRICRAIRNIPRRI   
EĞĨϳϯїϵϬ >ĞƵŬϵ Central Memory        QVPLRPMTYKAAFDLSFF   
   
VGFPVRP--------------- De Groot et al., ϮϬϬϱ͘ 
 
  
               ---------H-LKEKGGL Ranasinghe et al., ϮϬϭϮ 
EĞĨϭϮϵїϭϰϲ >ĞƵŬϭϬ Naïve PGPGVRYPLTFGWCFKLV   
   
    ----------Y---PVEPDKVEEANKG Pancré et al., ϮϬϬϳ 
ZĞǀϭϳїϯϰ >ĞƵŬϵ Central Memory RIIKILYQSNPYPKPEGT   
ZĞǀϰϵїϲϲ >ĞƵŬϭϬ Central Memory          QRQIHSISERILSTCLGR   
   
RRRRWRER--------- Blazevic et al., ϭϵϵϱ 
sŝĨϭїϭϴ >ĞƵŬϵ Central Memory MENRWQVLIVWQVDRMKI   
   
   ---------------RTWNSLVK De Groot et al., ϮϬϬϱ͘ 
sŝĨϴϭїϵϴ >ĞƵŬϭϬ Central Memory LGHGVSIEWRLRRYSTQV   
   
----------KQ---- Ranki et al., ϭϵϵϳ 
sƉƵϮїϮϬ >ĞƵŬϴ Central Memory ARVDYRLGVGALIVALII   
sƉƵϭϳїϯϰ >ĞƵŬϵ Central Memory IIAIVVWTIVYIEYRKLL   
sƉƵϯϯїϱϬ >ĞƵŬϭϬ Naïve LLRQRKIDWLIKRIRERA   
sƉƵϰϭїϱϴ >ĞƵŬϵ Central Memory WLIKRIRERAEDSGNESE   
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Table S3. HIV-1 specific epitopes mapped in the pre-exposure repertoire were compared against the Los Alamos database to establish whether they had 




HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
'ĂŐϯϯїϱϬ Leuk 7 Central Memory  HLVWASRELERFALNPGL   
   
     --------------L Ramduth et al.͕ϮϬϬϵ 
   
K-I-----------V Chevalier et al.͕ϮϬϭϭ 
   
K-I-----------V Kaufmann et al.͕ϮϬϬϰ 
   
 -I-----------VN Wahren et al., ϭϵϴϵ 
   
 -I-----------VN Koeppe et al., ϮϬϬϲ 
   
 -I-----------VN Jones et al., ϮϬϬϵ 
   
       -------VN Kaufmann et al., ϮϬϬϰ 
   
     -------------- Ranasinghe et al., ϮϬϭ2 
'ĂŐϰϭїϱϴ Leuk 7 Naïve LERFALNPGLLETSEGCK   
   
       ----------- Kaushik et al., ϮϬϬϱ 
   
 ----------------- Ramduth et al.͕ϮϬϬϵ 
'ĂŐϱϳїϳϰ Leuk 7 Central Memory CKQIIKQLQPALQTGTEE   
'ĂŐϳϯїϵϬ >ĞƵŬϵ Central Memory    EELRSLYNTVATLYCVHE   
   
TGS-------------- Chevalier et al.͕ϮϬϭϭ 
   
TGS-------------- Kaufmann et al.͕ϮϬϬϰ 
   
   --------------- Jones et al., ϮϬϬϵ 
 
  
   ----------------- Fonseca et al., ϮϬϬϲ 
'ĂŐϴϭїϵϴ >ĞƵŬϭϬ Naïve         TVATLYCVHEKIEVRDTK   
   
    SLYN---------QR--- Chevalier et al.͕ϮϬϭϭ 
   
    SLYN---------QR--- Kaufmann et al.͕ϮϬϬϰ 
   
    SLYN---------QR--- Geels et al., ϮϬϬϲ 
GĂŐϮϮϴїϮϰϱ >ĞƵŬϵ Central Memory MREPRGSDIAGTTSTLQE   
   
   ---------------QIGWM Boritz et al., ϮϬϬϳ 
   
     -------------QI Koeppe et al., ϮϬϬϲ 
'ĂŐϮϯϲїϮϱϯ >ĞƵŬϵ Central Memory      IAGTTSTLQEQIAWMTSN   
   
PRGSD--------------- Boritz et al., ϮϬϬϳ 
   
  GSD------------ Koeppe et al., ϮϬϬϲ 
   
              ---------PPVPVG Kaushik et al., ϮϬϬϱ 
 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are 
displayed with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
 HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
'ĂŐϮϲϬїϮϳϳ Leuk 7 Effector Memory    DIYKRWIILGLNKIVRMY   
   
PVG--------------- Ramduth et al.͕ϮϬϬϵ 
   
 VGE-----------------SPV De Groot et al., ϮϬϬϱ 
   
     ---------------- Boaz et al., ϮϬϬϯ 
   
     ---------------- Wilson et al., ϮϬϬϭ 
   
     ----------------SPTS Vingert et al., ϮϬϭϬ 
   
     ----------------SPTSILD Rosenberg et al., ϭϵϵϳ 
   
         ------------SP Koeppe et al., ϮϬϬϲ 
   
         ------------SP Jones et al., ϮϬϬϵ 
   
         ------------SPTSI Kaufmann et al., ϮϬϬϰ 
   
          ----------- Kaufmann et al., ϮϬϬϰ 
   
          -----------SPTSILDIR Adams et al., ϭϵϵϳ 
 
  
          -----------SPVSILDIRQGP De Groot et al., ϮϬϬϱ 
'ĂŐϮϲϴїϮϴϱ Leuk 7 Naïve           LGLNKIVRMYSPVSILDI   
   
          ------------T----- Ritchie et al., ϮϬϭϭ 
   
         I------------------RQGP De Groot et al., ϮϬϬϱ 
   
PVGDIYKRWI-------- Ramduth et al.͕ϮϬϬϵ 
   
VGEDIYKRWI------------- De Groot et al., ϮϬϬϱ 
   
     YKRWI---------- Boaz et al., ϮϬϬϯ 
   
     YKRWI----------- Wilson et al., ϮϬϬϭ 
   
     YKRWI------------T- Vingert et al., ϮϬϭϬ 
   
     YKRWI------------T---- Rosenberg et al., ϭϵϵϳ 
   
         I------------ Koeppe et al., ϮϬϬϲ 
   
         -------------- Jones et al., ϮϬϬϵ 
   
         --------------T-- Kaufmann et al., ϮϬϬϰ 
   
          ----------- Kaufmann et al., ϮϬϬϰ 
   
          -------------T----R Adams  et al., ϭϵϵϳ 
'ĂŐϮϳϲїϮϵϯ Leuk 7 Naïve          MYSPVSILDIKQGPKEPF   
   
ILGLNKIVR-------------- De Groot et al., ϮϬϬϱ 
   
 LGLNKIVR----------SPTSILD De Groot et al., ϮϬϬϱ 
   
              -------------RDYV Chevalier et al.͕ϮϬϭϭ 
   
               ------------RDYVDRFY Schrier et al., ϭϵϴϵ 
 
  
                   --------RDYVDR Younes et al., ϮϬϬϯ 
'ĂŐϮϵϮїϯϬϵ Leuk 7 Naïve           PFRDYVDRFFKTLRAEQA   
   
ILDIRQGPKE---------Y  Schrier et al., ϭϵϴϵ 
   
   IRQGPKE-------- Younes et al., ϮϬϬϯ 
   
      GPKE---------Y- Wahren  et al., ϭϵϴϵ 
   
      GPKE---------Y---- Kaufmann et al., ϮϬϬϰ 
   
      QPKE--------------- Adams et al., ϭϵϵϳ 
 
  
         E------------------S Boritz et al., ϮϬϬϳ 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are displayed 
with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
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HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
'ĂŐϯϵϳїϰϭϰ >ĞƵŬϭϬ Naïve KEGHIARNCRAPRKKGCW   
   
   ---K-----------K Kaufmann et al., ϮϬϬϰ 
 
  
   ---KN----------K Chevalier et al.͕ϮϬϭϭ 
'ĂŐϰϮϵїϰϰϲ Leuk 7 Naïve       RQANFLGKIWPSHKGRPG   
   
MKDCTE--------- Wahren et al., ϭϵϴϵ 
   
      ---------------- Kaufmann et al., ϮϬϬϰ 
   
      ---------------- Chevalier et al.͕ϮϬϭϭ 
   
            ------------NFLQSR Kaufmann et al., ϮϬϬϰ 
   
            ------------NFLQSR Ramduth  et al.͕ϮϬϬϵ 
   
            ------------NFLQSR Chevalier et al.͕ϮϬϭϭ 
'ĂŐϰϰϱїϰϲϮ Leuk 7 Naïve PGNFLQNRPEPTAPPAES   
 
Leuk 7 Naïve    ---S-----------FRF Chevalier et al.͕ϮϬϭϭ 
 
>ĞƵŬϭϬ Naïve  -----S---------   
'ĂŐϰϱϯїϰϳϮ Leuk 7 Naïve      PEPTAPPAESFRFEETTP   
   
FLQSR-------E----- Chevalier  et al.͕ϮϬϭϭ 
   
        ----E-----GEE---PSQK Kaufmann et al., ϮϬϬϰ 
'ĂŐϰϲϭїϰϴϬ Leuk 7 Naïve              ESFRFEETTPAPKQEPKD   
   
        TAPPE------------S-- Kaufmann et al., ϮϬϬϰ 
   
                 ----------- Kaushik et al., ϮϬϬϱ 
WŽůϯϭϯїϯϯϬ Leuk 7 Naïve   AIFQSSMTKILEPFRAQN   
   
SP------------- Wilson et al., ϮϬϬϭ 
   
SP------------- Boaz et al., ϮϬϬϯ 
WŽůϯϳϳїϯϵϰ Leuk 7 Central Memory QKEPPFLWMGYELHPDKW   
WŽůϳϭϯїϳϯϬ >ĞƵŬϭϬ Central Memory KVLFLDGIDKAQEEHEKY   
WŽůϳϳϳїϳϵϰ >ĞƵŬϲ Effector Memory QLDCTHLEGKIILVAVHV   
   
        ----------ASGYI Fonseca et al., ϮϬϬϲ 
WŽůϵϰϱїϵϲϮ Leuk 7 Central Memory SRDPIWKGPAKLLWKGEG   
Ŷǀϭїϭϵ >ĞƵŬϵ Central Memory MRVRGILRNCQQWWIWGI   
ŶǀϵїϮϳ >ĞƵŬϵ Central Memory NCQQWWIWGILGFWMLMI   
ŶǀϵϬїϭϬϳ Leuk 7 Naïve          TENFNMWKNDMVDQMHED   
   
PQEVVLVNV------------ Geretti et al., ϭϵϵϰ 
Ŷǀϭϰϴїϭϲϱ LĞƵŬϵ Central Memory          TNTMGEIKNCSFNITTEL   
 
>ĞƵŬϵ Central Memory TNPTSSSWGMMEK------- Mirano-Bascos et al., ϮϬϬϴ 
   
   SSSGRMIMEK---------- Geretti et al., ϭϵϵϰ 
   
          MEK------------SIRNK Mirano-Bascos et al., ϮϬϬϴ 
   
             ------------SIRGKVQK Geretti et al., ϭϵϵϰ 
 
 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are 
displayed with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
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 HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
Ŷǀϭϱϲїϭϳϯ >ĞƵŬϵ Central Memory       NCSFNITTELRDKKQKVY   
   
   GEIK-------TSIRG-V-- Geretti et al., ϭϵϵϰ 
   
MEKGEIK----Y---SIRNK Mirano-Bascos et al., ϮϬϬϴ 
 
  
      K----------I--- Gaudebout et al., ϭϵϵϳ 
Ŷǀϭϲϰїϭϴϭ >ĞƵŬϴ Effector Memory ELRDKKQKVYALFYRLDI   
   
        ----------VPLTK Harari et al., ϮϬϬϴ 
ŶǀϭϳϮїϭϴϵ >ĞƵŬϴ Effector Memory VYALFYRLDIVPLNENNS   
   
-------------TK Harari et al., ϮϬϬϴ 
ŶǀϮϭϯїϮϯϬ Leuk 7 Naïve       IPIHYCAPAGYAILKCNN   
   
     P----------F-------K Geretti et al., ϭϵϵϰ 
 
  
-----P----------F- Ranasinghe et al., ϮϬϭϮ  
ŶǀϮϲϵїϮϴϲ >ĞƵŬϭϬ Naïve EIIIRSENLTNNAKTIIV   
   
-DIV----F-D-------Q Mirano-Bascos et al., ϮϬϬϴ 
 
  
-VV-----F---------QLNES De Groot et al., ϮϬϬϰ 
ŶǀϮϳϳїϮϵϰ Leuk 7 Naïve       LTNNAKTIIVHLNESVEI   
   
     NF-D------------QIN Malhotra et al., ϮϬϬϯ 
   
 IRSVNF-D-------Q---T- Geretti et al., ϭϵϵϰ 
 
  
   SANF-D-------Q- Wahren et al., ϭϵϴϵ 
Env ϮϴϱїϯϬϮ Leuk 7 Naïve               IVHLNESVEIVCTRPNNN        
   
     NF-D------------QIN Malhotra et al., ϮϬϬϯ 
   
 IRSVNF-D-------Q---T- Geretti et al., ϭϵϵϰ 
Ŷǀϯϯϰїϯϱϭ Leuk 7 Central Memory SEDKWNKTLQKVSKKLKE   
  Leuk ϵ Central Memory     
ŶǀϯϰϮїϯϲϬ Leuk 7 Central Memory LQKVSKKLKEHFPNKTIK   
ŶǀϰϭϭїϰϮϴ Leuk 7 Central Memory NSTITLPCRIKQIINMWQ   
 
>ĞƵŬϭϬ Naïve  D----------------KVG Geretti et al., ϭϵϵϰ͘ 
   
 D----------------KVG Harari et al., ϮϬϬϴ 
   
   ---------------KVGKA Mirano-Bascos et al., ϮϬϬϴ 
   
        ----------KVGKA Koup et al., ϮϬϭϬ 
Env ϰϭϵїϰϯϲ Leuk 7 Naïve         RIKQIINMWQEVGRAMYA   
 
Leuk 7 Central Memory DTITLPC-------------- Geretti et al., ϭϵϵϰ͘ 
 
>ĞƵŬϭϬ Naïve DTITLPC-------------- Harari et al., ϮϬϬϴ 
   
  ITLQC--------------K- Mirano-Bascos et al., ϮϬϬϴ 
 
  
       --------------K- Koup et al., ϮϬϭϬ 
ŶǀϰϯϱїϰϱϮ Leuk 7 Naïve YAPPIAGNITCKSNITGL   
 
 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are displayed 
with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
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HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
Ŷǀϰϳϳїϰϵϰ Leuk 7 Naïve      DNWRSELYKYKVVEIKPL   
   
GGDMR--------------- Geretti et al., ϭϵϵϰ͘ 
   
  DMR------------ Wahren  et al., ϭϵϴϵ 
   
          -------K-----GVAPTKA Geretti et al., 1ϵϵϰ͘ 
 
  
           -------R----GVAPTRAK Mirano-Bascos et al., ϮϬϬϴ 
ŶǀϱϲϱїϱϴϮ Leuk ϵ Effector Memory    MLQLTVWGIKQLQTRVLA   
 
>ĞƵŬϴ Central Memory         -------------VERYLK Malhotra et al., ϮϬϬϯ 
   
QQHL----------- Wahren et al., ϭϵϴϵ 
ŶǀϲϭϯїϲϯϬ >ĞƵŬϴ Effector Memory SWSNKSQEDIWDNMTWMQ   
Ŷǀϲϲϵїϲϴϲ Leuk 7 Naïve   LWNWFDITNWLWYIKIFI   
   
AS-----N------- Wahren et al., ϭϵϴϵ 
ŶǀϳϮϱїϳϰϮ >ĞƵŬϵ Central Memory RGPDRLGRIEEEGGEQDR   
   
      ---------R--DR Schrier et al., ϭϵϴϵ 
ŶǀϳϯϯїϳϱϬ >ĞƵŬϵ Central Memory   IEEEGGEQDRDRSIRLVS   
   
GR---------R--DR Schrier et al., ϭϵϴϵ 
ŶǀϳϳϯїϳϵϬ >ĞƵŬϴ Effector Memory DFILIAARAVELLGRSSL   
ŶǀϳϵϬїϴϬϳ >ĞƵŬϲ Effector Memory           WEALKYLGSLVQYWGLEL   
 
>ĞƵŬϴ Central Memory RIVELLGRRG------------------KNSAVS Berzofsky et al., ϭϵϵϭ 
   
RIVELLGRRG------------------KNSAVS  Berzofsky et al., ϭϵϵϭ 
Ŷǀϳϵϴїϴϭϱ >ĞƵŬϲ Effector Memory SLVQYWGLELKKSAISLL   
ŶǀϴϯϬїϴϰϳ Leuk 7 Central Memory IELIQRICRAIRNIPRRI   
EĞĨϳϯїϵϬ >ĞƵŬϵ Central Memory        QVPLRPMTYKAAFDLSFF   
   
VGFPVRP--------------- De Groot et al., ϮϬϬϱ͘ 
 
  
               ---------H-LKEKGGL Ranasinghe et al., ϮϬϭϮ 
EĞĨϭϮϵїϭϰϲ >ĞƵŬϭϬ Naïve PGPGVRYPLTFGWCFKLV   
   
    ----------Y---PVEPDKVEEANKG Pancré et al., ϮϬϬϳ 
ZĞǀϭϳїϯϰ >ĞƵŬϵ Central Memory RIIKILYQSNPYPKPEGT   
ZĞǀϰϵїϲϲ >ĞƵŬϭϬ Central Memory          QRQIHSISERILSTCLGR   
   
RRRRWRER--------- Blazevic et al., ϭϵϵϱ 
sŝĨϭїϭϴ >ĞƵŬϵ Central Memory MENRWQVLIVWQVDRMKI   
   
   ---------------RTWNSLVK De Groot et al., ϮϬϬϱ͘ 
sŝĨϴϭїϵϴ >ĞƵŬϭϬ Central Memory LGHGVSIEWRLRRYSTQV   
   
----------KQ---- Ranki et al., ϭϵϵϳ 
sƉƵϮїϮϬ >ĞƵŬϴ Central Memory ARVDYRLGVGALIVALII   
sƉƵϭϳїϯϰ >ĞƵŬϵ Central Memory IIAIVVWTIVYIEYRKLL   
sƉƵϯϯїϱϬ >ĞƵŬϭϬ Naïve LLRQRKIDWLIKRIRERA   
sƉƵϰϭїϱϴ >ĞƵŬϵ Central Memory WLIKRIRERAEDSGNESE   
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Table S3. HIV-1 specific epitopes mapped in the pre-exposure repertoire were compared against the Los Alamos database to establish whether they had 




HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
'ĂŐϯϯїϱϬ Leuk 7 Central Memory  HLVWASRELERFALNPGL   
   
     --------------L Ramduth et al.͕ϮϬϬϵ 
   
K-I-----------V Chevalier et al.͕ϮϬϭϭ 
   
K-I-----------V Kaufmann et al.͕ϮϬϬϰ 
   
 -I-----------VN Wahren et al., ϭϵϴϵ 
   
 -I-----------VN Koeppe et al., ϮϬϬϲ 
   
 -I-----------VN Jones et al., ϮϬϬϵ 
   
       -------VN Kaufmann et al., ϮϬϬϰ 
   
     -------------- Ranasinghe et al., ϮϬϭ2 
'ĂŐϰϭїϱϴ Leuk 7 Naïve LERFALNPGLLETSEGCK   
   
       ----------- Kaushik et al., ϮϬϬϱ 
   
 ----------------- Ramduth et al.͕ϮϬϬϵ 
'ĂŐϱϳїϳϰ Leuk 7 Central Memory CKQIIKQLQPALQTGTEE   
'ĂŐϳϯїϵϬ >ĞƵŬϵ Central Memory    EELRSLYNTVATLYCVHE   
   
TGS-------------- Chevalier et al.͕ϮϬϭϭ 
   
TGS-------------- Kaufmann et al.͕ϮϬϬϰ 
   
   --------------- Jones et al., ϮϬϬϵ 
 
  
   ----------------- Fonseca et al., ϮϬϬϲ 
'ĂŐϴϭїϵϴ >ĞƵŬϭϬ Naïve         TVATLYCVHEKIEVRDTK   
   
    SLYN---------QR--- Chevalier et al.͕ϮϬϭϭ 
   
    SLYN---------QR--- Kaufmann et al.͕ϮϬϬϰ 
   
    SLYN---------QR--- Geels et al., ϮϬϬϲ 
GĂŐϮϮϴїϮϰϱ >ĞƵŬϵ Central Memory MREPRGSDIAGTTSTLQE   
   
   ---------------QIGWM Boritz et al., ϮϬϬϳ 
   
     -------------QI Koeppe et al., ϮϬϬϲ 
'ĂŐϮϯϲїϮϱϯ >ĞƵŬϵ Central Memory      IAGTTSTLQEQIAWMTSN   
   
PRGSD--------------- Boritz et al., ϮϬϬϳ 
   
  GSD------------ Koeppe et al., ϮϬϬϲ 
   
              ---------PPVPVG Kaushik et al., ϮϬϬϱ 
 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are 
displayed with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
 HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
'ĂŐϮϲϬїϮϳϳ Leuk 7 Effector Memory    DIYKRWIILGLNKIVRMY   
   
PVG--------------- Ramduth et al.͕ϮϬϬϵ 
   
 VGE-----------------SPV De Groot et al., ϮϬϬϱ 
   
     ---------------- Boaz et al., ϮϬϬϯ 
   
     ---------------- Wilson et al., ϮϬϬϭ 
   
     ----------------SPTS Vingert et al., ϮϬϭϬ 
   
     ----------------SPTSILD Rosenberg et al., ϭϵϵϳ 
   
         ------------SP Koeppe et al., ϮϬϬϲ 
   
         ------------SP Jones et al., ϮϬϬϵ 
   
         ------------SPTSI Kaufmann et al., ϮϬϬϰ 
   
          ----------- Kaufmann et al., ϮϬϬϰ 
   
          -----------SPTSILDIR Adams et al., ϭϵϵϳ 
 
  
          -----------SPVSILDIRQGP De Groot et al., ϮϬϬϱ 
'ĂŐϮϲϴїϮϴϱ Leuk 7 Naïve           LGLNKIVRMYSPVSILDI   
   
          ------------T----- Ritchie et al., ϮϬϭϭ 
   
         I------------------RQGP De Groot et al., ϮϬϬϱ 
   
PVGDIYKRWI-------- Ramduth et al.͕ϮϬϬϵ 
   
VGEDIYKRWI------------- De Groot et al., ϮϬϬϱ 
   
     YKRWI---------- Boaz et al., ϮϬϬϯ 
   
     YKRWI----------- Wilson et al., ϮϬϬϭ 
   
     YKRWI------------T- Vingert et al., ϮϬϭϬ 
   
     YKRWI------------T---- Rosenberg et al., ϭϵϵϳ 
   
         I------------ Koeppe et al., ϮϬϬϲ 
   
         -------------- Jones et al., ϮϬϬϵ 
   
         --------------T-- Kaufmann et al., ϮϬϬϰ 
   
          ----------- Kaufmann et al., ϮϬϬϰ 
   
          -------------T----R Adams  et al., ϭϵϵϳ 
'ĂŐϮϳϲїϮϵϯ Leuk 7 Naïve          MYSPVSILDIKQGPKEPF   
   
ILGLNKIVR-------------- De Groot et al., ϮϬϬϱ 
   
 LGLNKIVR----------SPTSILD De Groot et al., ϮϬϬϱ 
   
              -------------RDYV Chevalier et al.͕ϮϬϭϭ 
   
               ------------RDYVDRFY Schrier et al., ϭϵϴϵ 
 
  
                   --------RDYVDR Younes et al., ϮϬϬϯ 
'ĂŐϮϵϮїϯϬϵ Leuk 7 Naïve           PFRDYVDRFFKTLRAEQA   
   
ILDIRQGPKE---------Y  Schrier et al., ϭϵϴϵ 
   
   IRQGPKE-------- Younes et al., ϮϬϬϯ 
   
      GPKE---------Y- Wahren  et al., ϭϵϴϵ 
   
      GPKE---------Y---- Kaufmann et al., ϮϬϬϰ 
   
      QPKE--------------- Adams et al., ϭϵϵϳ 
 
  
         E------------------S Boritz et al., ϮϬϬϳ 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are displayed 
with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
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HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
'ĂŐϯϵϳїϰϭϰ >ĞƵŬϭϬ Naïve KEGHIARNCRAPRKKGCW   
   
   ---K-----------K Kaufmann et al., ϮϬϬϰ 
 
  
   ---KN----------K Chevalier et al.͕ϮϬϭϭ 
'ĂŐϰϮϵїϰϰϲ Leuk 7 Naïve       RQANFLGKIWPSHKGRPG   
   
MKDCTE--------- Wahren et al., ϭϵϴϵ 
   
      ---------------- Kaufmann et al., ϮϬϬϰ 
   
      ---------------- Chevalier et al.͕ϮϬϭϭ 
   
            ------------NFLQSR Kaufmann et al., ϮϬϬϰ 
   
            ------------NFLQSR Ramduth  et al.͕ϮϬϬϵ 
   
            ------------NFLQSR Chevalier et al.͕ϮϬϭϭ 
'ĂŐϰϰϱїϰϲϮ Leuk 7 Naïve PGNFLQNRPEPTAPPAES   
 
Leuk 7 Naïve    ---S-----------FRF Chevalier et al.͕ϮϬϭϭ 
 
>ĞƵŬϭϬ Naïve  -----S---------   
'ĂŐϰϱϯїϰϳϮ Leuk 7 Naïve      PEPTAPPAESFRFEETTP   
   
FLQSR-------E----- Chevalier  et al.͕ϮϬϭϭ 
   
        ----E-----GEE---PSQK Kaufmann et al., ϮϬϬϰ 
'ĂŐϰϲϭїϰϴϬ Leuk 7 Naïve              ESFRFEETTPAPKQEPKD   
   
        TAPPE------------S-- Kaufmann et al., ϮϬϬϰ 
   
                 ----------- Kaushik et al., ϮϬϬϱ 
WŽůϯϭϯїϯϯϬ Leuk 7 Naïve   AIFQSSMTKILEPFRAQN   
   
SP------------- Wilson et al., ϮϬϬϭ 
   
SP------------- Boaz et al., ϮϬϬϯ 
WŽůϯϳϳїϯϵϰ Leuk 7 Central Memory QKEPPFLWMGYELHPDKW   
WŽůϳϭϯїϳϯϬ >ĞƵŬϭϬ Central Memory KVLFLDGIDKAQEEHEKY   
WŽůϳϳϳїϳϵϰ >ĞƵŬϲ Effector Memory QLDCTHLEGKIILVAVHV   
   
        ----------ASGYI Fonseca et al., ϮϬϬϲ 
WŽůϵϰϱїϵϲϮ Leuk 7 Central Memory SRDPIWKGPAKLLWKGEG   
Ŷǀϭїϭϵ >ĞƵŬϵ Central Memory MRVRGILRNCQQWWIWGI   
ŶǀϵїϮϳ >ĞƵŬϵ Central Memory NCQQWWIWGILGFWMLMI   
ŶǀϵϬїϭϬϳ Leuk 7 Naïve          TENFNMWKNDMVDQMHED   
   
PQEVVLVNV------------ Geretti et al., ϭϵϵϰ 
Ŷǀϭϰϴїϭϲϱ LĞƵŬϵ Central Memory          TNTMGEIKNCSFNITTEL   
 
>ĞƵŬϵ Central Memory TNPTSSSWGMMEK------- Mirano-Bascos et al., ϮϬϬϴ 
   
   SSSGRMIMEK---------- Geretti et al., ϭϵϵϰ 
   
          MEK------------SIRNK Mirano-Bascos et al., ϮϬϬϴ 
   
             ------------SIRGKVQK Geretti et al., ϭϵϵϰ 
 
 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are 
displayed with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
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 HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
Ŷǀϭϱϲїϭϳϯ >ĞƵŬϵ Central Memory       NCSFNITTELRDKKQKVY   
   
   GEIK-------TSIRG-V-- Geretti et al., ϭϵϵϰ 
   
MEKGEIK----Y---SIRNK Mirano-Bascos et al., ϮϬϬϴ 
 
  
      K----------I--- Gaudebout et al., ϭϵϵϳ 
Ŷǀϭϲϰїϭϴϭ >ĞƵŬϴ Effector Memory ELRDKKQKVYALFYRLDI   
   
        ----------VPLTK Harari et al., ϮϬϬϴ 
ŶǀϭϳϮїϭϴϵ >ĞƵŬϴ Effector Memory VYALFYRLDIVPLNENNS   
   
-------------TK Harari et al., ϮϬϬϴ 
ŶǀϮϭϯїϮϯϬ Leuk 7 Naïve       IPIHYCAPAGYAILKCNN   
   
     P----------F-------K Geretti et al., ϭϵϵϰ 
 
  
-----P----------F- Ranasinghe et al., ϮϬϭϮ  
ŶǀϮϲϵїϮϴϲ >ĞƵŬϭϬ Naïve EIIIRSENLTNNAKTIIV   
   
-DIV----F-D-------Q Mirano-Bascos et al., ϮϬϬϴ 
 
  
-VV-----F---------QLNES De Groot et al., ϮϬϬϰ 
ŶǀϮϳϳїϮϵϰ Leuk 7 Naïve       LTNNAKTIIVHLNESVEI   
   
     NF-D------------QIN Malhotra et al., ϮϬϬϯ 
   
 IRSVNF-D-------Q---T- Geretti et al., ϭϵϵϰ 
 
  
   SANF-D-------Q- Wahren et al., ϭϵϴϵ 
Env ϮϴϱїϯϬϮ Leuk 7 Naïve               IVHLNESVEIVCTRPNNN        
   
     NF-D------------QIN Malhotra et al., ϮϬϬϯ 
   
 IRSVNF-D-------Q---T- Geretti et al., ϭϵϵϰ 
Ŷǀϯϯϰїϯϱϭ Leuk 7 Central Memory SEDKWNKTLQKVSKKLKE   
  Leuk ϵ Central Memory     
ŶǀϯϰϮїϯϲϬ Leuk 7 Central Memory LQKVSKKLKEHFPNKTIK   
ŶǀϰϭϭїϰϮϴ Leuk 7 Central Memory NSTITLPCRIKQIINMWQ   
 
>ĞƵŬϭϬ Naïve  D----------------KVG Geretti et al., ϭϵϵϰ͘ 
   
 D----------------KVG Harari et al., ϮϬϬϴ 
   
   ---------------KVGKA Mirano-Bascos et al., ϮϬϬϴ 
   
        ----------KVGKA Koup et al., ϮϬϭϬ 
Env ϰϭϵїϰϯϲ Leuk 7 Naïve         RIKQIINMWQEVGRAMYA   
 
Leuk 7 Central Memory DTITLPC-------------- Geretti et al., ϭϵϵϰ͘ 
 
>ĞƵŬϭϬ Naïve DTITLPC-------------- Harari et al., ϮϬϬϴ 
   
  ITLQC--------------K- Mirano-Bascos et al., ϮϬϬϴ 
 
  
       --------------K- Koup et al., ϮϬϭϬ 
ŶǀϰϯϱїϰϱϮ Leuk 7 Naïve YAPPIAGNITCKSNITGL   
 
 
Sequence identified in T cell library assay is presented in bold font. Previously reported epitopes containing shared sequence homology (represented by dashed line (-)) to mapped epitopes are displayed 
with accompanying literature reference. Gray highlighting indicates peptide epitopes that have not been identified before. 
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HBX2 location Subject ID CD4+ T cell subset Sequence Reference 
Ŷǀϰϳϳїϰϵϰ Leuk 7 Naïve      DNWRSELYKYKVVEIKPL   
   
GGDMR--------------- Geretti et al., ϭϵϵϰ͘ 
   
  DMR------------ Wahren  et al., ϭϵϴϵ 
   
          -------K-----GVAPTKA Geretti et al., 1ϵϵϰ͘ 
 
  
           -------R----GVAPTRAK Mirano-Bascos et al., ϮϬϬϴ 
ŶǀϱϲϱїϱϴϮ Leuk ϵ Effector Memory    MLQLTVWGIKQLQTRVLA   
 
>ĞƵŬϴ Central Memory         -------------VERYLK Malhotra et al., ϮϬϬϯ 
   
QQHL----------- Wahren et al., ϭϵϴϵ 
ŶǀϲϭϯїϲϯϬ >ĞƵŬϴ Effector Memory SWSNKSQEDIWDNMTWMQ   
Ŷǀϲϲϵїϲϴϲ Leuk 7 Naïve   LWNWFDITNWLWYIKIFI   
   
AS-----N------- Wahren et al., ϭϵϴϵ 
ŶǀϳϮϱїϳϰϮ >ĞƵŬϵ Central Memory RGPDRLGRIEEEGGEQDR   
   
      ---------R--DR Schrier et al., ϭϵϴϵ 
ŶǀϳϯϯїϳϱϬ >ĞƵŬϵ Central Memory   IEEEGGEQDRDRSIRLVS   
   
GR---------R--DR Schrier et al., ϭϵϴϵ 
ŶǀϳϳϯїϳϵϬ >ĞƵŬϴ Effector Memory DFILIAARAVELLGRSSL   
ŶǀϳϵϬїϴϬϳ >ĞƵŬϲ Effector Memory           WEALKYLGSLVQYWGLEL   
 
>ĞƵŬϴ Central Memory RIVELLGRRG------------------KNSAVS Berzofsky et al., ϭϵϵϭ 
   
RIVELLGRRG------------------KNSAVS  Berzofsky et al., ϭϵϵϭ 
Ŷǀϳϵϴїϴϭϱ >ĞƵŬϲ Effector Memory SLVQYWGLELKKSAISLL   
ŶǀϴϯϬїϴϰϳ Leuk 7 Central Memory IELIQRICRAIRNIPRRI   
EĞĨϳϯїϵϬ >ĞƵŬϵ Central Memory        QVPLRPMTYKAAFDLSFF   
   
VGFPVRP--------------- De Groot et al., ϮϬϬϱ͘ 
 
  
               ---------H-LKEKGGL Ranasinghe et al., ϮϬϭϮ 
EĞĨϭϮϵїϭϰϲ >ĞƵŬϭϬ Naïve PGPGVRYPLTFGWCFKLV   
   
    ----------Y---PVEPDKVEEANKG Pancré et al., ϮϬϬϳ 
ZĞǀϭϳїϯϰ >ĞƵŬϵ Central Memory RIIKILYQSNPYPKPEGT   
ZĞǀϰϵїϲϲ >ĞƵŬϭϬ Central Memory          QRQIHSISERILSTCLGR   
   
RRRRWRER--------- Blazevic et al., ϭϵϵϱ 
sŝĨϭїϭϴ >ĞƵŬϵ Central Memory MENRWQVLIVWQVDRMKI   
   
   ---------------RTWNSLVK De Groot et al., ϮϬϬϱ͘ 
sŝĨϴϭїϵϴ >ĞƵŬϭϬ Central Memory LGHGVSIEWRLRRYSTQV   
   
----------KQ---- Ranki et al., ϭϵϵϳ 
sƉƵϮїϮϬ >ĞƵŬϴ Central Memory ARVDYRLGVGALIVALII   
sƉƵϭϳїϯϰ >ĞƵŬϵ Central Memory IIAIVVWTIVYIEYRKLL   
sƉƵϯϯїϱϬ >ĞƵŬϭϬ Naïve LLRQRKIDWLIKRIRERA   
sƉƵϰϭїϱϴ >ĞƵŬϵ Central Memory WLIKRIRERAEDSGNESE   
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